Spots Global Cancer Trial Database for oligometastatic disease
Every month we try and update this database with for oligometastatic disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC | NCT05846646 | Oligometastatic... | IMSA101 Immune checkpoi... PULSAR | 18 Years - | ImmuneSensor Therapeutics Inc. | |
| Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC | NCT05277844 | Oligometastatic... Non-small Cell ... Driver Mutation | Local Consolida... TKI | 18 Years - 99 Years | Tata Memorial Hospital | |
| MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer | NCT05183074 | Prostate Cancer Radiotherapy Si... Magnetic Resona... Stereotactic Ab... Adaptive Radiot... Localised Disea... Oligometastatic... | MR-linac | 18 Years - | ChineseAMS | |
| Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy | NCT05233540 | Anal Cancer Locally Advance... Oligometastatic... Circulating Tum... Human Papilloma... | 18 Years - | Aarhus University Hospital | ||
| Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas | NCT04617457 | Pancreatic Canc... Metastasis Surgery Oligometastatic... | nal-irinotecan ... | 18 Years - | University of Cologne | |
| Prediction of True Oligo-metastatic Disease. | NCT05806151 | Oligometastatic... | Genetic and imm... | 18 Years - | National Cancer Institute, Naples | |
| A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation | NCT03955198 | NSCLC | Radiotherapy + ... | 18 Years - | Institut Claudius Regaud | |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | NCT06430411 | Prostate Cancer... Prostate Cancer... Prostate Cancer Prostate Neopla... Oligometastatic... Oligometastasis | Radical prostat... Prostate irradi... Surgical metast... Irradiation of ... Abiraterone ace... Enzalutamide Darolutamide Apalutamide Docetaxel Lutetium-PSMA Androgen depriv... | 18 Years - 80 Years | Medical University of Vienna | |
| Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare Tumors | NCT05903261 | Oligometastatic... | SBRT | 18 Years - | Istituto Clinico Humanitas | |
| Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC | NCT05951127 | Esophageal Squa... Oligometastatic... | Esophagectomy | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression | NCT06180356 | Ovarian Cancer Oligometastatic... Serous Ovarian ... | Niraparib oral ... | 18 Years - | MedSIR | |
| Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy | NCT05233540 | Anal Cancer Locally Advance... Oligometastatic... Circulating Tum... Human Papilloma... | 18 Years - | Aarhus University Hospital | ||
| RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer | NCT05862051 | Colorectal Canc... Oligometastatic... | Local Ablative ... Standard first-... | 18 Years - | Australasian Gastro-Intestinal Trials Group | |
| Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma | NCT06122480 | Pancreatic Duct... Oligometastatic... | FOLFIRINOX chem... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases | NCT04973007 | Oligometastatic... Liver Metastase... Colorectal Canc... | Gadoxetate diso... Gadobenate dime... | 18 Years - | University of Colorado, Denver | |
| TERPS Trial for de Novo Oligometastic Prostate Cancer | NCT05223803 | Prostate Cancer Oligometastatic... | Prostate radiat... Systemic Therap... Stereotactic ab... | 18 Years - | University of Maryland, Baltimore | |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | NCT06430411 | Prostate Cancer... Prostate Cancer... Prostate Cancer Prostate Neopla... Oligometastatic... Oligometastasis | Radical prostat... Prostate irradi... Surgical metast... Irradiation of ... Abiraterone ace... Enzalutamide Darolutamide Apalutamide Docetaxel Lutetium-PSMA Androgen depriv... | 18 Years - 80 Years | Medical University of Vienna | |
| Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer | NCT06299852 | HER2-positive M... Oligometastatic... | Trastuzumab emt... | 18 Years - | N.N. Petrov National Medical Research Center of Oncology | |
| Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer | NCT04141709 | Oligometastatic... Prostatic Cance... | local ablative ... | 18 Years - | Technische Universität Dresden | |
| Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer | NCT04821765 | Esophagus Cance... Chemoradiothera... Oligometastatic... Immunotherapy | PD-1 antibody Chemoradiation Albumin-Bound P... Cisplatin | 18 Years - | ChineseAMS | |
| Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer | NCT05377047 | Breast Cancer S... Oligometastatic... | SABR | 18 Years - | Vastra Gotaland Region | |
| RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer | NCT05862051 | Colorectal Canc... Oligometastatic... | Local Ablative ... Standard first-... | 18 Years - | Australasian Gastro-Intestinal Trials Group | |
| Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer | NCT06439888 | Oligometastatic... Solid Tumor, Ad... | all-trans retin... Stereotactic Bo... | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC | NCT05278052 | Oligometastatic... Metastatic Non ... | Local consolida... Standard mainte... | 18 Years - 99 Years | Tata Memorial Hospital | |
| Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery | NCT05648370 | Non-small Cell ... Oligometastatic... | ctDNA testing a... | 18 Years - | Guangdong Provincial People's Hospital | |
| Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma | NCT05128201 | Oligometastatic... | consolidative r... | 18 Years - 70 Years | Jiangxi Provincial Cancer Hospital | |
| Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma | NCT05128201 | Oligometastatic... | consolidative r... | 18 Years - 70 Years | Jiangxi Provincial Cancer Hospital | |
| Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer | NCT00807313 | Colon Cancer Rectal Cancer Colorectal Canc... | 18 Years - | Universitair Ziekenhuis Brussel | ||
| Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC | NCT06219317 | NSCLC Stage IV | Cemiplimab Placebo | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease | NCT06356779 | Oligometastatic... Metastases Ablation Techni... Radiotherapy Stereotactic Ra... Surgery | Local ablative ... | 18 Years - | Herlev Hospital | |
| Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC | NCT05277844 | Oligometastatic... Non-small Cell ... Driver Mutation | Local Consolida... TKI | 18 Years - 99 Years | Tata Memorial Hospital | |
| TERPS Trial for de Novo Oligometastic Prostate Cancer | NCT05223803 | Prostate Cancer Oligometastatic... | Prostate radiat... Systemic Therap... Stereotactic ab... | 18 Years - | University of Maryland, Baltimore | |
| Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy | NCT05233540 | Anal Cancer Locally Advance... Oligometastatic... Circulating Tum... Human Papilloma... | 18 Years - | Aarhus University Hospital | ||
| Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer | NCT00807313 | Colon Cancer Rectal Cancer Colorectal Canc... | 18 Years - | Universitair Ziekenhuis Brussel | ||
| Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery | NCT05648370 | Non-small Cell ... Oligometastatic... | ctDNA testing a... | 18 Years - | Guangdong Provincial People's Hospital | |
| Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) | NCT04748042 | Prostate Cancer Castrate Sensit... Oligometastatic... | Abiraterone Prednisone External Beam R... Androgen Depriv... Olaparib | 18 Years - | University of Michigan Rogel Cancer Center | |
| Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients With Muscle Invasive Bladder Cancer | NCT04724928 | Muscle-Invasive... | Metastasis dire... Immunotherapy Standard of car... | 18 Years - | University Hospital, Ghent | |
| Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC | NCT05917431 | Unresectable He... Oligometastatic... | SBRT plus tisle... | 18 Years - | Peking University Cancer Hospital & Institute | |
| Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma | NCT05128201 | Oligometastatic... | consolidative r... | 18 Years - 70 Years | Jiangxi Provincial Cancer Hospital | |
| Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare Tumors | NCT05903261 | Oligometastatic... | SBRT | 18 Years - | Istituto Clinico Humanitas | |
| Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma | NCT06122480 | Pancreatic Duct... Oligometastatic... | FOLFIRINOX chem... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
